Pamela Monteith

3.2k total citations · 3 hit papers
10 papers, 2.5k citations indexed

About

Pamela Monteith is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Pamela Monteith has authored 10 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 8 papers in Hepatology and 4 papers in Molecular Biology. Recurrent topics in Pamela Monteith's work include Liver Disease and Transplantation (8 papers), Liver Disease Diagnosis and Treatment (7 papers) and Gut microbiota and health (4 papers). Pamela Monteith is often cited by papers focused on Liver Disease and Transplantation (8 papers), Liver Disease Diagnosis and Treatment (7 papers) and Gut microbiota and health (4 papers). Pamela Monteith collaborates with scholars based in United States and United Kingdom. Pamela Monteith's co-authors include Melanie B. White, Nicole A. Noble, Douglas M. Heuman, Jasmohan S. Bajaj, Phillip B. Hylemon, Kalyani Daita, Masoumeh Sikaroodi, Patrick M. Gillevet, Arun J. Sanyal and Jason M. Ridlon and has published in prestigious journals such as PLoS ONE, Hepatology and Gut.

In The Last Decade

Pamela Monteith

10 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Altered profile of human gut microbiome is associated with cirrhosis and its complications

2013 810 citations Jasmohan S. Bajaj, Douglas M. Heuman et al. Journal of Hepatology profile →
Modulation of the fecal bile acid profile by gut microbiota in cirrhosis

2013 619 citations Genta Kakiyama, William M. Pandak et al. Journal of Hepatology profile →
Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation

2012 414 citations Jasmohan S. Bajaj, Phillip B. Hylemon et al. American Journal of Physiology-Gastrointestinal and Liver Physiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pamela Monteith United States	9	1.5k	1.3k	1.1k	521	470	10	2.5k
Nicole A. Noble United States	16	2.3k 1.5×	1.4k 1.1×	2.0k 1.8×	921 1.8×	552 1.2×	21	3.6k
Kalyani Daita United States	14	2.4k 1.6×	1.9k 1.5×	1.4k 1.3×	612 1.2×	751 1.6×	22	3.7k
Chathur Acharya United States	24	1.3k 0.9×	739 0.6×	836 0.8×	823 1.6×	298 0.6×	61	2.2k
Andrew Fagan United States	31	2.1k 1.4×	1.7k 1.3×	1.5k 1.4×	646 1.2×	617 1.3×	89	3.5k
Ding Shi China	25	766 0.5×	1.5k 1.2×	315 0.3×	297 0.6×	397 0.8×	50	2.5k
Daiqiong Fang China	23	699 0.5×	1.4k 1.1×	292 0.3×	261 0.5×	377 0.8×	36	2.3k
Audrey L. Shaw United States	13	912 0.6×	377 0.3×	769 0.7×	771 1.5×	291 0.6×	34	2.3k
Tarkan Karakan Türkiye	27	553 0.4×	620 0.5×	231 0.2×	630 1.2×	352 0.7×	101	2.3k
Tilman Bauer Germany	17	728 0.5×	277 0.2×	676 0.6×	347 0.7×	126 0.3×	25	1.9k
Razan Alkhouri United States	10	1.1k 0.7×	1.2k 0.9×	140 0.1×	265 0.5×	722 1.5×	19	2.1k

Countries citing papers authored by Pamela Monteith

Since Specialization

Citations

This map shows the geographic impact of Pamela Monteith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela Monteith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela Monteith more than expected).

Fields of papers citing papers by Pamela Monteith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pamela Monteith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela Monteith. The network helps show where Pamela Monteith may publish in the future.

Co-authorship network of co-authors of Pamela Monteith

This figure shows the co-authorship network connecting the top 25 collaborators of Pamela Monteith. A scholar is included among the top collaborators of Pamela Monteith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamela Monteith. Pamela Monteith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Bajaj, Jasmohan S., Douglas M. Heuman, Arun J. Sanyal, et al.. (2013). Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy. PLoS ONE. 8(4). e60042–e60042. 322 indexed citations

Bajaj, Jasmohan S., Leroy R. Thacker, Douglas M. Heuman, et al.. (2013). The Stroop Smartphone Application Is A Short And Valid Method To Screen for Minimal Hepatic Encephalopathy. Hepatology. 58(3). 1122–1132. 162 indexed citations

Thacker, Leroy R., James B. Wade, Richard K. Sterling, et al.. (2013). Diagnosis of Covert Hepatic Encephalopathy Without Specialized Tests. Clinical Gastroenterology and Hepatology. 12(8). 1384–1389.e2. 55 indexed citations

Kakiyama, Genta, William M. Pandak, Patrick M. Gillevet, et al.. (2013). Modulation of the fecal bile acid profile by gut microbiota in cirrhosis. Journal of Hepatology. 58(5). 949–955. 619 indexed citations breakdown →

Bajaj, Jasmohan S., Douglas M. Heuman, Phillip B. Hylemon, et al.. (2013). Altered profile of human gut microbiome is associated with cirrhosis and its complications. Journal of Hepatology. 60(5). 940–947. 810 indexed citations breakdown →

Heuman, Douglas M., A. K. Sanyal, Phillip B. Hylemon, et al.. (2013). 192 RIFAXIMIN IMPROVES COGNITION AND ENDOTOXEMIA IN MINIMAL HEPATIC ENCEPHALOPATHY BY SHIFTING GUT MICROBIAL FUNCTIONALITY WITHOUT ALTERING THEIR ABUNDANCE. Journal of Hepatology. 58. S84–S85. 1 indexed citations

Bajaj, Jasmohan S., Vishwadeep Ahluwalia, James B. Wade, et al.. (2012). Asymmetric dimethylarginine is strongly associated with cognitive dysfunction and brain MR spectroscopic abnormalities in cirrhosis. Journal of Hepatology. 58(1). 38–44. 26 indexed citations

Bajaj, Jasmohan S., Phillip B. Hylemon, Jason M. Ridlon, et al.. (2012). Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. American Journal of Physiology-Gastrointestinal and Liver Physiology. 303(6). G675–G685. 414 indexed citations breakdown →

Imtiaz, Komal, Pamela Monteith, & A A Khaleeli. (2000). Complete histological regression of metastatic carcinoid tumour after treatment with octreotide. Clinical Endocrinology. 53(6). 755–758. 32 indexed citations

10.

Coddington, R. Dean, et al.. (1993). Extraintestinal lymphoma in association with Whipple's disease.. Gut. 34(11). 1627–1629. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact